MAM. L. Adamyan

M. L. Adamyan

*This is an algorithmically generated author record based on publicly available information.

M. L. Adamyan has a total of 64 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Morphological characteristics of An3Ca endometrioid carcinoma and visceral organs in female nude mice with experimental diabetes mellitus

    by A. I. Shikhlyarova, E. M. Frantsiyants, I. V. Neskubina, V. A. Bandovkina, L. K. Trepitaki, P. S. Kachesova, E. A. Ozerkova, A. P. Menshenina, M. L. Adamyan, O. E. Zhenilo, et al.

    Purpose of the study . To investigate the morphological features of induced An3Ca endometrioid carcinoma and visceral organs in BALB/c nude mice under conditions of diabetes mellitus. Materials and methods . Female BALB/c nude mice weighing 25 ± 2.5 g were used to model uterine tumor growth under conditions of diabetes mellitus. The animals were divided into two experimental groups: group 1 (control) – intrauterine growth of endometrioid carcinoma (n = 5); group 2 (study group) – intrauterine growth of endometrioid carcinoma in the presence of diabetes mellitus (n = 5). Sections of the tumor nodules and organs (uterus, ovaries, liver, lungs, thyroid gland, adrenal glands, and pancreas) were examined microscopically, with images captured using a digital camera. Results . Tumor growth without alloxan administration resulted in the formation of a single tumor nodule in the right uterine horn, with preservation of the main morphological features of its architecture. In contrast, alloxan administration was associated with the formation of a tumor consisting of several separate nodules that completely obliterated the structure of the right ovary and replaced it with tumor tissue. Metastatic involvement of the liver accompanied by vascular congestion of the parenchyma was observed. In the lungs, destruction of the alveolar and bronchial structures was accompanied by vascular congestion, foci of hemorrhage, mucus accumulation in the airway lumens, and the presence of tumor cells. Marked thickening of the colloid was observed throughout the thyroid follicles. Involutional changes were noted in the X-zone and zona glomerulosa of the adrenal cortex, with focal expansion of the zona fasciculata. Diabetes modeling resulted in almost complete loss of the exocrine pancreatic parenchyma, exposing the stromal framework of the organ. Its morphological identity could be established only from isolated small areas of degeneratively altered acini and rare remnants of the islets of Langerhans. Conclusion . In the experimental bimodal model combining two pathological processes, cancer and diabetes mellitus, morphological evidence of mutually reinforcing mechanisms of adverse systemic effects involving multiple organs was observed. This pronounced synergistic effect was manifested by stimulation of tumor progression and pathological changes in visceral organs, expanding our understanding of cancer pathogenesis in the presence of comorbid disease.

  • Features of steroid hormone and receptor content in the mitochondria of endometrial adenocarcinoma according to tumor differentiation grade and the presence of type 2 diabetes mellitus

    by V. A. Bandovkina, E. M. Frantsiyants, E. A. Ozerkova, E. I. Surikova, I. V. Neskubina, A. I. Shikhlyarova, A. P. Menshenina, M. L. Adamyan, A. O. Adamyan, Yu. A. Fomenko, et al.

    Mitochondria play a key role in cellular metabolism, steroid hormone synthesis, and the regulation of redox homeostasis. However, the role of mitochondrial steroidogenesis in the progression of endometrial adenocarcinoma (EA), particularly in the presence of type 2 diabetes mellitus (T2DM), remains poorly understood. Purpose of the study. To determine the concentrations of steroid hormones and their receptors in the mitochondrial fraction of G1–G3 endometrial adenocarcinoma tissue compared with intact endometrium and to evaluate the modifying effect of type 2 diabetes mellitus on these parameters. Patients and methods. Mitochondria were isolated by differential centrifugation from tumor tissue obtained from 92 patients with endometrial adenocarcinoma (G1–G3) and from morphologically normal endometrium (control group). Standard enzyme-linked immunosorbent assay (ELISA) kits were used to determine the concentrations of estradiol (E2), estriol (E3), estrone (E1) and their receptors (ERα, ERβ), testosterone (T) and the androgen receptor (AR), progesterone (P4) and the progesterone receptor (PR), as well as cortisol and cholesterol. Statistical analysis was performed using Statistica 10 software. Results. In the mitochondria of G1–G2 endometrial adenocarcinomas, the estradiol level was approximately twofold higher than in the control group, whereas G3 tumors demonstrated an approximately twofold increase in estriol concentration. Testosterone and cortisol levels were elevated in the mitochondria of all tumors by 1.6-fold and more than twofold, respectively. Progesterone content was increased by 2.3–3.8-fold in the mitochondria of G1–G2 tumors but decreased by 4.3–5.9-fold in comparison with the control mitochondria. The levels of androgen and estrogen receptors were elevated in the mitochondria of all tumors, whereas the ERα/ERβ ratio decreased by 1.7–3.6-fold. Progesterone receptor levels were increased in G1–G2 mitochondria only in patients with T2DM, whereas in G3 tumors they were elevated regardless of T2DM status. Type 2 diabetes mellitus was associated with cholesterol accumulation in the mitochondria of all tumors. Conclusion. Regardless of tumor differentiation grade and the presence of type 2 diabetes mellitus, endometrial adenocarcinoma mitochondria are characterized by increased levels of testosterone, cortisol, and sex hormone receptors, reflecting profound metabolic reprogramming of these organelles. Estradiol predominates in G1–G2 tumors, whereas estriol is the dominant estrogen in G3 tumors, which may contribute to increased tumor aggressiveness. Type 2 diabetes mellitus is associated with mitochondrial cholesterol accumulation, which may partly explain the more severe clinical course of endometrial adenocarcinoma in these patients.

  • Open Access

    Study of the intensity of free radical oxidation in mitochondria of endometrioid adenocarcinoma cells depending on the degree of tumor differentiation

    by E. M Frantsiyants, I. V. Kaplieva, I. V. Neskubina, A. I. Shikhlyarova, Yu. A. Petrova, L. K. Trepitaki, V. A. Bandovkina, E. I. Surikova, T. I. Moiseenko, M. L. Adamyan, et al.

    Purpose of the study . To investigate redox-balance parameters in mitochondria of endometrioid adenocarcinoma (EA) cells in oncogynecological patients, as well as in mitochondria of Guerin carcinoma cells with intramural tumor localization in rats. Materials and methods . The clinical part of the study included patients who underwent surgical treatment for EA (n = 42) and uterine fibroids (n = 14). Among patients with EA, 16 had well-differentiated tumors (G1), 12 had moderately differentiated tumors (G2), and 14 had poorly differentiated tumors (G3). The mean age of patients with EA was 60.8 ± 2.9 years, and with fibroids – 49.4 ± 2.5 years. None of the patients received neoadjuvant therapy. The experimental part of the study included biological material obtained from non-linear white female laboratory rats (n = 15) weighing 250 ± 25 g. Intramural growth of Guerin carcinoma was reproduced in these animals. In mitochondria isolated from EA, fibroid, and intact uterine tissues, concentrations of the following parameters were determined using standard ELISA methods: mitochondrial superoxide dismutase (SOD‑2), DNA and RNA oxidative modification products, malondialdehyde (MDA), diene conjugates (DC), and total protein (biuret method). Statistical analysis was performed using Statistica 10.0. Results . In women, mitochondria of EA cells in G1 tumors demonstrated a markedly elevated content of MDA and DC – 2.3‑fold and 2.9‑fold higher, respectively, compared with values in mitochondria of intact uterine tissue. In G2 tumors, MDA levels were 3.2‑fold higher and DC levels 2.7‑fold higher than in intact mitochondria. In G3 tumors, the degree of DNA damage increased 1.6‑fold (p < 0.05), while MDA, DC, and SOD‑2 concentrations increased 2.4‑fold, 3.0‑fold, and 3.4‑fold, respectively, compared with intact values. In female rats, mitochondria isolated from tumor tissues with intramural Guerin carcinoma growth displayed changes similar in direction to the clinical results: DNA damage increased 1.6‑fold (p < 0.05), MDA 1.6‑fold (p < 0.05), DC 1.5‑fold (p < 0.05), and SOD‑2 2.4‑fold. Conclusion . The oxidative stress and mitochondrial dysfunction identified in malignant cells of women indicate a differentiationdependent pathogenetic feature. Additionally, an identical direction of redox-balance alterations was demonstrated in the experimental subcellular model, supporting the translational relevance of the findings.


  • Open Access

    Concentrations of pro- and anti-apoptotic proteins, as well as calcium ions in mitochondria of endometrioid adenocarcinoma cells depending on the degree of its differentiation

    by E. M. Frantsiyants, I. V. Kaplieva, I. V. Neskubina, Yu. А. Petrova, A. P. Menshenina, L. K. Trepitaki, N. S. Lesovaya, V. A. Bandovkina, E. I. Surikova, M. L. Adamyan, et al.

    Purpose of the study. To study the concentration of calcium ions, pro- and antiapoptotic proteins (cytochrome C, AIF-1, and Bcl-2) in the mitochondria of endometrioid adenocarcinoma (EA) cells in oncogynecological patients, depending on the degree of differentiation of malignant cells.Patients and methods. The study included patients who had undergone surgical treatment for endometrial adenocarcinoma (n = 42) and uterine fibroids (n = 14). The patients with endometrial adenocarcinoma were further classified as having highly differentiated (G1) disease, moderately differentiated (G2) disease, or poorly differentiated (G3) disease. The average age of patients with endometrial adenocarcinoma was 60.8 ± 2.9 years, and the average age of patients with fibroids was 49.4 ± 2.5 years. It is noteworthy that the patients in this study did not receive any neoadjuvant treatment. The concentration of cytochrome C (ng/mg protein), AIF (pg/mg protein), Bcl-2 (pg/mg protein), and calcium (mM/mg protein) was determined in the mitochondria of EA, fibroids, and intact uterus cells by ELISA. The statistical analysis of the results was performed using the Statistica 10.0 software package.Results. A decline in the degree of tumor cell differentiation was accompanied by a decrease in calcium levels within the mitochondria, with G2 and G3 exhibiting an average reduction of 2.0 times compared to the intact uterus. Furthermore, the Bcl-2 content in the tumor mitochondria at G3 demonstrated an average increase of 1.9 times compared to G1 and G2 (p < 0.05). Furthermore, the cytochrome C level at G1 was found to be 2.2 times higher than at G2 and 1.9 times higher (p < 0.05) than at G3. In the mitochondria of cells with G3 differentiation, the highest AIF-1 values were observed, which were 2.1 times higher than in intact cells and 1.9 times higher (p < 0.05) compared to the values in the mitochondria of myoma cells.Conclusions. It is hypothesized that the process of apoptosis is suppressed in the mitochondria of endometrioid adenocarcinoma cells due to an accumulation of Bcl-2 and a decrease in calcium. This accumulation of Bcl-2 and decrease in calcium activates energy processes, leading to the accumulation of cytochrome C and AIF-1. The severity of the biochemical events identified in the mitochondria of endometrioid adenocarcinoma increases with the degree of malignancy of the tumor cells. This increase in severity appears to contribute to an escalation in the aggressiveness of the tumor.

  • Open Access

    Features of some growth factors content in tumors and blood plasma in patients with rare forms of endometrial cancer

    by E. M. Frantsiyants, V. A. Bandovkina, T. I. Moiseenko, A. P. Menshenina, M. A. Rogozin, I. V. Kaplieva, E. I. Surikova, I. V. Neskubina, Yu. A. Petrova, N. D. Cheryarina, et al.

    Purpose of the study. The objective of the present study was to examine the levels of TGFβ1, EGF, and EGFR in the blood and tissue of morphologically distinct endometrial tumors, including uterine serous carcinoma (USC), clear cell endometrial cancer (CCEC), and G3 endometrioid adenocarcinoma (EAC).Patients and methods. The study encompassed 61 patients diagnosed with uterine body cancer, including 21 patients with USC, 20 patients with CCEC, and 20 patients with EAC (G3). All patients underwent a thorough morphological verification of the disease, as documented in the postoperative report. The level of epidermal growth factor and its receptor (EGF and EGFR), as well as transforming growth factor (TGFb1), was determined in cytosolic fractions of 10 % tumor homogenates and blood samples using standard ELISA kits. Samples of intact endometrium obtained from patients who underwent surgery for uterine fibroids (n = 20) and blood samples from conditionally healthy women (n = 20) of the same age served as normal indicators. Statistical analysis of the results was performed using the Statistica 10.0 software package.Results. EAC (G3) was characterized by an increased, compared to the healthy, content of growth factors and their receptors in tumor and blood samples. In tumor samples of CCEC and USC, the level of TGFβ1 was lower by 2.2 times and 1.6 times, respectively, and the concentration of EGF was on average more than 2 times lower, compared to the indicators in the intact endometrium. The content of these same growth factors in blood samples in patients with rare forms of EC exceeded the normative values by 2.1–4.2 times.Conclusion. The investigation revealed that low levels of EGF were present in tumor samples of rare forms of endometrial cancer, accompanied by unaltered levels of EGFR and TGFβ1. This observation stands in contrast to the elevated concentrations of these growth factors detected in blood samples. The distinctive profile of these growth factors in tumor samples differentiates them from the indicators observed in EAC tissue, where the levels of EGFR and TGFβ1 are augmented. It is plausible that the altered metabolism of non-endometrioid uterine cancers leads to alterations in the biological characteristics of tumors, consequently resulting in a more aggressive clinical course.

  • Open Access

    Free radical oxidation and antioxidant defense in uterine myoma and endometrioid adenocarcinoma depending on its degree of differentiation

    by E. I. Surikova, E. M. Frantsiyants, I. V. Kaplieva, V. A. Bandovkina, L. A. Nemashkalova, I. V. Neskubina, T. I. Moiseenko, A. P. Menshenina, M. A. Rogozin, E. V. Verenikina, et al.

    Purpose of the study. To evaluate the features of free radical oxidation (FRO) and the principal enzymatic and non-enzymatic links of antioxidant defense in proliferating tissues of benign myoma and malignant endometrioid adenocarcinoma (EA) with varying degrees of differentiation.Patients and methods. Patients who received surgical treatment for EA (n = 42) and uterine myoma (n = 14) were examined. Patients with stage Ia (n = 26) and stage Ib (n = 16) of disease were selected. 16 patients had highly differentiated (G1) EA, 12 had moderately differentiated (G2) EA, and 14 had low-differentiated (G3) EA. The activity of superoxide dismutase (SOD), catalase, glutathione peroxidase (GPx), glutathione transferase (GST), reduced glutathione (GSH), vitamins A and E, lipid peroxidation products diene conjugates (DC) and malondialdehyde (MDA) were determined colorimetrically in the tissues of EA, myoma and intact uterus.Results. Compared with the level in intact tissue, SOD decreased by 3.2 times and GST increased by 2.7 times in myoma (p < 0.01). Similar changes were noted for EA G1 – on average by 5.3 times (p < 0.01) and also DC increased by 2.2 times (p < 0.05). In EA G2 tissue, SOD and GPx activities were lower than in the intact tissue, by 5.7 and 4.5 times, respectively (p < 0.05), and lower GST, GPx and GSH than in the EA G1, by 4.9, 8.9 and 1.6 times, respectively (p < 0.05 – p < 0.01). In EA G3 tissue, there was an increase in GSH, GPx and GST from 1.5 to 7.1 times (p < 0.05 – p < 0.01) and lipid peroxidation products by an average of 2.5 times (p < 0.05), as well as a decrease in vitamins A and E by 2.9 and 4.6 times, respectively (p < 0.05) compared with the intact tissue. The tissue of the EA G2 had a minimal level of activity of the GSH-dependent system.Conclusion. The results reflect the differences in the mechanisms of proliferation regulation by FRO in myomas and in the EA tissue with changes in its differentiation. Knowledge of the characteristics of individual links in the regulation of FRO can play a certain role in the use of antioxidant therapy for benign or malignant tumors of the uterus.


  • The role of androgens in the pathogenesis of endometrial cancer

    by T.I. Moiseenko, E.M. Frantsiyants, A.P. Menshenina, V.A. Bandovkina, M.L. Adamyan, M.A. Rogozin, N.D. Cheryarina

    Over the past decades, endometrial cancer has become the most common gynecological cancer worldwide. Its increasing incidence cannot be attributed only to the increasing age of women in socially secure countries. The leading risk factor for the endometrial cancer development is obesity, and its epidemic is gradually covering the female population of North Africa, Europe and Asia. Endometrial cancer is pathogenetically associated with hyperestrogenism, and this was the basis for the dualistic theory of clinical and pathological variants proposed by Ya.V. Bohman. The foundations of this theory about the hormonal dependence of endometrial cancer are now being actively supplemented by molecular genetic parameters of the TCGA classification. Recent studies show steroid dependence of endometrial cancer both on estrogens and, to a large extent, on androgens which are directly involved in the complex processes of transformation into estrogens. Published research data, rather contradictory and ambiguous, confirm the antiproliferative role of androgens in the pathogenesis of endometrial cancer. This review analyzes papers on the role of androgens in pathogenesis and their potential clinical antitumor application. Keywords: endometrial cancer, androgens, androgen receptor, classification of endometrial cancer.

  • Pathogenetic characteristics of endometrioid adenocarcinoma of uterus at present stage

    by T. I. Moiseenko, S. V. Shatalova, E. M. Nepomnyashchaya, V. A. Bandovkina, M. L. Adamyan

    Endometrial cancer (EC) is one of the most common cancers with a constantly and steadily growing incidence worldwide. The main reason for EC development, in addition to the female population aging, involves the obesity epidemic and associated hyperinsulinemia. Screening for EC has not been developed. However, endometrial carcinoma (ECa) demonstrates a specific symptomatology and clinical picture, and diagnostic methods are available, sensitive and defined by a certain range of comorbid diseases. These factors allow early ECa diagnosis in 80 %. The methods of treatment are standardized, depending on the stage of RTM and the morphological structure of EC, the age of the patient and allow to achieve 72–76 % of the overall 5-year survival rate. The methods of treatment are standardized, depending on the EC stage, the morphological structure of ECa, and the patient’s age, and allow achieving the 5-year overall survival of 72–76 %. The disease promised a favorable outcome and seemed to be controlled. However, at the end of the last century, researchers started to report the clinical and morphological heterogeneity of ECa, which allowed Ya. V. Bohman to propose a dichotomous division of EC into clinical and pathological variants. Such a division was accepted all over the world and required re-evaluation of the prognostic value of various endometrial adenocarcinoma histotypes depending on the phenotype and hormonogenesis of ECa. Initially, adenosquamous cancer (or endometrioid adenocarcinoma with squamous metaplasia, in the modern classification) was also classified as estrogen-dependent endometrioid adenocarcinoma, and squamous cell endometrial cancer was classified as an unfavorable type with a poor prognosis and without hormonal influence. Interest in the squamous cell component in dimorphic endometrial adenocarcinoma has repeatedly arisen over the past decades due to its unpredictable clinical course. The newest TCGA molecular classification of EC did not clarify the issues, but gave rise to new ones related to the etiology and carcinogenesis of this ECa histotype and its clinical interpretation.


  • Open Access

    Changes in urine metabolite concentration as a minimally invasive marker of ovarian serous adenocarcinoma

    by О. Н. Гуськова, I. A. Alliluev, E. V. Verenikina, V. V. Polovodova, M. A. Rogozin, T. Yu. Myagkova, M. L. Adamyan, O. E. Zhenilo, N. M. Abdullaeva, M. R. Tsandekova, et al.

    Introduction. Detection of ovarian cancer (OC) at the earliest possible stages is a priority for gynecological oncology, since 5-year survival rates decrease significantly with the progression of the disease. Currently, there is a huge need for more effective diagnostic methods and approaches. In recent years, fluid biopsy has received increasing attention in precision medicine because it is minimally invasive and can be repeated many times, allowing for realtime disease monitoring.Aim. Study of the urine metabolomic profile of patients with ovarian carcinoma.Materials and methods. To perform metabolomic analysis, 50 urine samples from patients with a diagnosis of serous ovarian carcinoma and 20 samples from apparently healthy individuals were selected. For protein precipitation, 300 mkl of urine was mixed with 600 mkl of a solution of acetonitrile LC-MS (Merck, Germany) and methanol LC-MS (Merck, Germany) (3:1 ratio). Chromatographic separation of metabolites was performed on a Vanquish Flex UHPLC System chromatograph (Thermo Scientific, Germany). The chromatograph was coupled to an Orbitrap Exploris 480 mass spectrometer (Thermo Scientific, Germany) equipped with an electrospray ionization source. Chromatographic separation was carried out on a Hypersil GOLD™ C18 column (1.9mkm, 10 x 2.1 mm) using the following eluents: A, 0.1 % formic acid; B, acetonitrile containing 0.1 % formic acid.Results. A total of 417 metabolites of various classes were identified by HPLC-MS. It was shown that in the urine of patients with OC 14 metabolites (kynurenine, phenylalanyl-valine, lysophosphatidylcholine (18:3), lysophosphatidylcholine (18:2), alanyl-leucine, lysophosphatidylcholine (20:4), L-phenylalanine, phosphatidylinositol (34:1), 5-methoxytryptophan, 2-hydroxymyristic acid, 3-oxocholic acid, lysophosphatidylcholine (14:0), indoleacrylic acid, lysophosphatidylserine (20:4)) had a significantly higher concentration compared to apparently healthy individuals. The content of 12 compounds, on the contrary, was reduced (L-beta-aspartyl-L-phenylalanine, myristic acid, decanoylcarnitine, aspartyl-glycine, malonylcarnitine, 3-hydroxybutyrylcarnitine, 3-methylxanthine, 2,6-dimethylheptanoylcarnitine, 3-oxododecanoic acid, N-acetylproline, L-octanoylcarnitine, capryloylglycine). This indicates a significant metabolomic imbalance in patients with OC.Conclusion. The metabolomic profile study of urine by UHPLC-MS showed that in patients with serous ovarian carcinoma there is an imbalance in the content of certain fatty acids and their derivatives, acylcarnitines, phospholipids, amino acids and their derivatives, as well as some derivatives of nitrogenous bases. At the same time, 26 metabolites with abnormal concentrations in urine may have some potential as non-invasive biomarkers of OC in women belonging to high-risk groups.


  • Open Access

    Levels of sex steroids in lung tissues of patients with non‑small cell lung cancer after COVID‑19 of different severity

    by O. I. Kit, E. M. Frantsiyants, D. A. Kharagezov, V. A. Bandovkina, A. I. Shikhlyarova, N. D. Cheryarina, Yu. A. Pogorelova, Yu. N. Lazutin, A. G. Milakin, I. A. Leyman, et al.

    The purpose of the study. To analyze levels of sex hormones and cortisol in lung tissues of patients with lung cancer with previous COVID‑19 of different severity.Materials and methods. The material for the study included samples of lung tissues obtained after open biopsy at radical surgery from 60 patients with morphologically verified stage I–IIIA non‑small cell lung cancer (NSCLC) (сT1–3NХ M0). The mean age of patients was 59.11 ± 2.9 years. All patients had negative results of SARS‑CoV‑2 nasopharyngeal swab PCR testing at hospitalization. Based on the anamnestic data collected using a special questionnaire, the main and control groups were formed depending on COVID‑19 severity. The main group included 30 NSCLC patients (15 men and 15 women) after severe or moderate COVID‑19 who had required hospitalization; the control group included 30 patients with NSCLC after asymptomatic or mild SARS‑CoV‑2 infection. All patients underwent COVID‑19 infection for 3 months or more before the start of NSCLC treatment. Quantitative assessment of estradiol (E2), testosterone (T), progesterone (P4) and cortisol (C) was performed by RIA in 10 % homogenates of the tumor and resection line tissues.Results. Resection line tissues in women of the main group showed an increase of E2 by 1.7 times, C by 1.6 times, P4 by 4.1 times, and a decrease of T by 1.3 times; in men, levels of T and P4 were increased on average by 1.8 times (p < 0.05). Tumor samples in men and women of the main group demonstrated increased E2 by 1.7 times, and C by 1.8 times in women only (p < 0.05).Conclusions. Severe COVID‑19 changed the hormonal profile of unaffected lung tissues, especially in women, and the tumor itself. Most likely, we should expect the increase in the incidence of lung cancer, especially in females, and also changes in its course, response to antitumor therapy and, possibly, higher rates of complications and adverse outcomes.